| Investor protection, taxation, and dividends M Alzahrani, M Lasfer Journal of Corporate Finance 18 (4), 745-762, 2012 | 150 | 2012 |
| Systematic risk and time scales: New evidence from an application of wavelet approach to the emerging Gulf stock markets M Masih, M Alzahrani, O Al-Titi International Review of Financial Analysis 19 (1), 10-18, 2010 | 99 | 2010 |
| Linear and non-linear Granger causality between oil spot and futures prices: A wavelet based test M Alzahrani, M Masih, O Al-Titi Journal of International Money and Finance 48, 175-201, 2014 | 95 | 2014 |
| Managerial behavior and the link between stock mispricing and corporate investments: Evidence from Market‐to‐Book ratio decomposition M Alzahrani, RP Rao Financial Review 49 (1), 89-116, 2014 | 54 | 2014 |
| Practices, awareness and attitudes toward self-medication of analgesics among health sciences students in Riyadh, Saudi Arabia M Al Essa, A Alshehri, M Alzahrani, R Bustami, S Adnan, A Alkeraidees, ... Saudi Pharmaceutical Journal 27 (2), 235-239, 2019 | 53 | 2019 |
| Islamic corporate finance, financial markets, and institutions: an overview M Alzahrani Journal of Corporate Finance 55, 1-5, 2019 | 41 | 2019 |
| Radiographic diagnosis of periapical status and quality of root canal fillings in a Saudi Arabian subpopulation K Alfouzan, JK Baskaradoss, A Geevarghese, M Alzahrani, K Alhezaimi Oral Health Prev Dent 14 (3), 241-8, 2016 | 34 | 2016 |
| Finance as worship: a survey of Islamic finance research M Alzahrani, WL Megginson CEIF Discussion Paper (4/2017), 2017 | 31 | 2017 |
| The impact of taxation on dividends: A cross-country analysis M Alzahrani, M Lasfer Available at SSRN 1343826, 2009 | 18 | 2009 |
| Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis MS Al Yami, HA Badreldin, AH Mohammed, AM Elmubark, MY Alzahrani, ... Journal of thrombosis and thrombolysis 46, 145-153, 2018 | 15 | 2018 |
| Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer W Abdel-Razaq, M Alzahrani, M Al Yami, F Almugibl, M Almotham, ... Journal of Pharmacy and Bioallied Sciences 11 (4), 348-354, 2019 | 11 | 2019 |
| Experience of and attitudes toward research among pharmaceutical sciences and PharmD students in Saudi Arabia RA Alqahtani, MA Aldahash, SA Alhulail, MY Alzahrani, L Alfehaid, ... Health Professions Education 5 (1), 58-65, 2019 | 10 | 2019 |
| Comparative risk of acute kidney injury following concurrent administration of vancomycin with piperacillin/tazobactam or meropenem: A systematic review and meta-analysis of … AM Alshehri, MY Alzahrani, MA Abujamal, MH Abdalla, SA Alowais, ... Antibiotics 11 (4), 526, 2022 | 9 | 2022 |
| The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines NS Alsubaie, SM Al Rammah, RA Alshouimi, MY Alzahrani, MS Al Yami, ... Thrombosis Journal 19, 1-11, 2021 | 8 | 2021 |
| The use of direct oral anticoagulants for extended duration thromboprophylaxis in medically ill patients: a systematic review and meta-analysis RA Alshouimi, SM Al Rammah, MY Alzahrani, HA Badreldin, MS Al Yami, ... Journal of thrombosis and thrombolysis 48, 422-429, 2019 | 8 | 2019 |
| Knowledge and awareness of authorship practices among health science students: a cross-sectional study H Badreldin, S Aloqayli, R Alqarni, H Alyahya, A Alshehri, M Alzahrani, ... Advances in Medical Education and Practice, 383-392, 2021 | 7 | 2021 |
| Practices, awareness and attitudes toward selfmedication of analgesics among health sciences students in Riyadh, Saudi Arabia. Saudi Pharm J. 2019 Feb; 27 (2): 235-239 M Al Essa, A Alshehri, M Alzahrani, R Bustami, S Adnan, A Alkeraidees PubMed, 0 | 7 | |
| Exploring patient’s perceptions of cancer chemotherapy side effects W Abdel-Razaq, M Alzahrani, R Bustami, Y Alolah, M Almutlag Education 60, 60, 2017 | 6 | 2017 |
| Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis RM Altoukhi, RA Alshouimi, SM Al Rammah, MY Alzahrani, AR Almutairi, ... BMJ open 10 (9), e036138, 2020 | 5 | 2020 |
| Real-World Effectiveness and Safety of Apixaban versus Warfarin in patients with acute venous thromboembolism: experience of a large tertiary hospital in Saudi Arabia MS Al Yami, MY Alzahrani, AM Alshehri, OA Alshaya, NS Alsubiae, ... International Journal of General Medicine, 4031-4037, 2021 | 4 | 2021 |
